Quizartinib for treating relapsed or refractory acute myeloid leukaemia [ID1325]
Discontinued
Reference number: GID-TA10363
Please note that following an update received from the company, the NICE appraisal committee discussion on Wednesday 2 October 2019 has been cancelled and will be rescheduled in due course.
NICE will continue to monitor any development and further information regarding the timelines of this appraisal will be available once known.